Meet an Unreasonable Venture
CyanoCapture
Bringing affordable carbon capture to emitting industries worldwide.
Around 27% of essential drugs on the FDA list are categorised as 'at risk' due to uncertain supply chains. CyanoCapture is an advanced Synthetic Biology company that is leveraging the world's fastest carbon-negative cell to synthesise drugs like insulin at lower cost and address this problem. The award winning technology using the world's fastest photosynthetic cell won the Elon Musk's XPRIZE 2021.
Notable Achievements
- Raised $4.49M in equity financing from VCs and angels and a further $5M in non-dilutive prizes.
- Secured $27m in LOIs and pre-orders for non-Pharma grade insulin.
- Won Elon Musk's XPRIZE 2021 + another $4million from international prizes/grants.
Currently Operating in One Region
Work at CyanoCapture
More Ventures in Energy & Environment
Get the Unreasonable Newsletter
Get monthly updates on CyanoCapture and all of the other ventures working to solve global challenges.